Colin Dayan, M.A. M.B.B.S., F.R.C.P., Ph.D.
Professor of Clinical Diabetes and Metabolism, Cardiff University School of Medicine Professor of Endocrinology and Diabetes, University of Bristol
Colin Dayan serves as the Chair of Clinical Diabetes and Metabolism and Head of Section at Cardiff University School of Medicine. He is a Professor of Endocrinology and Diabetes at the University of Bristol, UK as a joint post with Cardiff. Previously, he was the Director of the Institute of Molecular and Experimental Medicine.
Colin conducts early phase clinical trials in the development of antigen specific immunotherapy and leading multicenter phase 2 studies. He is the lead for diabetes in the Cardiff whole pancreas transplantation program and helps lead an All Wales anonymized data linkage program for monitoring childhood T1D. He has been a member of the JDRF Medical and Scientific Committee and the Welsh Diabetes Research Unit. Currently, Colin leads the Clinical Engagement and Training Core of the Diabetes UK funded type 1 diabetes UK immunotherapy Consortium. He also chairs the UK Clinical Studies Group for the prevention and therapies in T1D.
Colin received his M.D. from University College, Oxford, and Guy’s and Charing Cross Hospitals in London, UK and his Ph.D. in the immunology of Graves’ Disease. He was an endocrine fellow at the Massachusetts General Hospital and completed his specialist training in diabetes and endocrinology as a Lecturer in Bristol.